Traws Pharma, Inc.

8-K Delisting notice or listing-rule failure Jul 31, 2026 8-K Other events Jul 10, 2026 8-K Director or officer change; Shareholder vote results Jul 9, 2026 8-K Regulation FD disclosure Jun 22, 2026 8-K Regulation FD disclosure Jun 12, 2026 8-K Regulation FD disclosure May 27, 2026 8-K Other events May 26, 2026 10-Q Quarter ended 2026-03-31 May 15, 2026 8-K Results of operations (earnings release); Regulation FD disclosure May 15, 2026 10-K/A Fiscal year ended 2025-12-31 Apr 30, 2026 10-K Fiscal year ended 2025-12-31 Apr 15, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Apr 15, 2026 8-K Entered a material agreement; Unregistered sale of equity; Other events Apr 15, 2026 8-K Other events Feb 19, 2026 8-K Other events Jan 26, 2026 8-K Other events Jan 13, 2026 8-K Other events Dec 17, 2025 8-K Director or officer change Dec 16, 2025 8-K Director or officer change; Shareholder vote results Nov 28, 2025 10-Q Quarter ended 2025-09-30 Nov 13, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Nov 13, 2025 8-K Director or officer change Oct 17, 2025 8-K Other events Oct 14, 2025 8-K Director or officer change; Regulation FD disclosure Oct 6, 2025 8-K Entered a material agreement; Completed an acquisition or disposition Sep 12, 2025 8-K Regulation FD disclosure; Other events Aug 18, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Aug 14, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 8-K Director or officer change Jul 3, 2025 8-K Regulation FD disclosure; Other events Jun 30, 2025 8-K Regulation FD disclosure; Other events Jun 3, 2025 8-K Regulation FD disclosure; Other events May 27, 2025 8-K Regulation FD disclosure May 19, 2025 10-Q Quarter ended 2025-03-31 May 15, 2025 8-K Results of operations (earnings release); Regulation FD disclosure May 15, 2025 10-K/A Fiscal year ended 2024-12-31 Apr 30, 2025 8-K Director or officer change; Other events Apr 18, 2025 8-K Other events Apr 7, 2025 10-K Fiscal year ended 2024-12-31 Mar 31, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Mar 31, 2025